Formosa Pharmaceuticals and Medvisis Switzerland Announce Licensing Agreement for the Treatment of Post-Operative Inflammation and Pain
Ownership: Privately owned by Medvisis Leadership team (Aktiengesellschaft); no 3rd party debt financing
Unterstützt von